{"url_path":"/sec/nnvc/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1379006/0001104659-26-061499-index.html","accession_number":"0001104659-26-061499","cik":"0001379006","ticker":"NNVC","issuer_name":"NANOVIRICIDES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1379006/0001104659-26-061499-index.html","primary_entity_key":"0001379006","primary_entity_name":"NANOVIRICIDES, INC."},"word_count":264,"has_tables":true,"body_markdown":"**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**\n\nFor the three and nine months ended March 31, 2026, the Company’s Board of Directors authorized the issuance of 39,113 and 175,576, respectively, fully vested shares of its common stock with a restrictive legend for consulting and legal services. The Company recorded expense of $43,250 and $244,100, respectively, for the three and nine months ended March 31, 2026, which is reflective of the fair value of the common stock on the dates of issuance.\n\nFor the three and nine months ended March 31, 2026, the Company’s Board of Directors authorized the issuance of 10,690 and 26,165, fully vested shares of its common stock with a restrictive legend for director services, respectively. The Company recorded an expense of $11,250 and $33,750 for the three and nine months ended March 31, 2026, which is reflective of the fair value of the common stock on the dates of issuance.\n\nAll of the securities referred to above were issued without registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as provided in Rule 506(b) of Regulation D promulgated thereunder. None of the foregoing securities as well as common stock issuable upon conversion or exercise of such securities, have been registered under the Securities Act or any other applicable laws and are deemed restricted securities, and unless so registered may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act."}